Skip to content
Technical & commercial enquiries: sales@rssechem.com Certificate of analysis issued per lot · Worldwide shipping
Register Request a quote & Contact us

Cleaning validation residue limits: where the number comes from

Impurities & regulation Published By RSSE Technical Team · Reviewed by RSSE Quality Unit

A cleaning limit is arithmetic, not a convention. This works through the three routes that produce it, shows where each one fails, and then follows the number down to the swab, the recovery correction and the standard sitting on the balance.

On this page

A residue limit belongs to a product pair, not to a substance

Equipment shared between products carries a limit that neither product owns on its own. It is set by the compound left behind, by the batch that will be made next, and by the surfaces the two share. Change the recipient batch size, add a third product to the train, or revise the toxicology of the donor, and the number moves while the cleaning procedure stays exactly as it was. Programmes that treat the limit as a fixed property of the residue end up revalidating against a figure that no longer describes the plant.

The arithmetic runs in two stages. The first gives a maximum allowable carryover, MACO: a mass of donor residue, in milligrams, permitted across the whole recipient batch. The second divides that mass by the shared product-contact area, producing a surface limit in micrograms per square centimetre, which is the only form an analyst can actually test.

MACO = (daily limit for the donor x minimum batch size of the recipient) / maximum daily dose of the recipient

A daily limit in milligrams divided by a daily dose in milligrams leaves a dimensionless fraction, and the fraction multiplies a batch mass. The formula carries no safety judgement of its own; all of the judgement sits in the choice of the donor limit.

Three routes, and the lowest one governs

Most programmes compute every route they can and adopt the smallest result. That is not conservatism for its own sake: the routes fail in different directions, so the smallest figure is the only one that survives an argument about the other two.

RouteWhat it needsWhere it fails
A fraction of the therapeutic dose, usually one thousandth of the minimum daily dosea studied or approved human dose for the donorblind to effects that are not an extension of the pharmacological dose, and undefined for an intermediate that is never dosed
A concentration ceiling of 10 ppm in the recipient batchbatch size alone no toxicological content at all; loose for a potent active, needlessly tight for a benign one
A health-based exposure limit, written as PDE or ADEa toxicological assessment with a no-effect level and adjustment factorsneeds a qualified assessor and a written report; an unfamiliar compound may have no usable data
Visually cleantrained inspectors, defined lighting, a defined viewing distancethe eye detects far above the limit for a potent active, and it is not a number

The visual criterion deserves its own paragraph because it is the one most often misused. It is a necessary condition and never a sufficient one. Detection thresholds for residues on stainless steel sit in the low micrograms per square centimetre, and they shift with the residue and the lighting. Where the calculated limit falls below what an eye can resolve, a shiny surface proves that the cleaning step did something, not that it did enough.

The health-based route, worked through

The health-based route borrows its arithmetic from the residual solvent methodology of ICH Q3C, which derives a permitted daily exposure from a no-observed-effect level:

PDE = (NOEL x body weight) / (F1 x F2 x F3 x F4 x F5)

The body weight term is 50 kg by convention, deliberately below the 60 and 70 kg figures used elsewhere so that the result errs low. The five factors cover extrapolation between species, variability between individuals, the duration of the study, the severity of the effect, and whether only a lowest-observed-effect level was available.

FactorCoversValues in common use
F1extrapolation between species2 from dog, 2.5 from rabbit, 3 from monkey, 5 from rat, 12 from mouse, 10 from other species
F2variability between individuals10 by default
F3duration of the study1 for a study covering half a lifetime or a full organogenesis window, 2 for six months in rodents, 5 for three months, 10 for less
F4severity of the effect1 where no severe toxicity was seen, up to 10 for a teratogenic effect without maternal toxicity
F5no no-effect level established1 when a no-effect level exists, up to 10 where only a lowest-observed-effect level is available

A chronic rat study with a no-effect level of 5 mg/kg/day, no severe findings and a proper no-effect level gives 5 multiplied by 50, divided by 5 multiplied by 10, which is 5 mg/day. That figure becomes the donor side of the MACO equation. Run the same equation on an elemental impurity and the answer arrives in micrograms, which is the subject of the elemental impurity piece; the logic is identical.

Two failures recur at this step. The first is a PDE quoted without its report: a figure on a spreadsheet with no assessment behind it cannot be defended once the input data are questioned. The second is a compound with no threshold at all. A mutagenic impurity carrying a structural alert has no no-effect level to divide, so its acceptable intake is derived another way and lands in the microgram-per-day region; there the health-based route governs by two or three orders of magnitude. The reasoning is set out in the ICH M7 walkthrough.

From a mass in the batch to a number on the swab

Take one donor and one recipient on a shared train: minimum daily dose of the donor 1.0 mg, PDE of the donor 0.15 mg/day, maximum daily dose of the recipient 400 mg, minimum batch of the recipient 50 kg, shared product-contact area 25,000 square centimetres.

RouteMass permitted in the batch Surface limit
Dose fraction, 0.001 x 1.0 mg125 mg5 micrograms per square centimetre
10 ppm of a 50 kg batch500 mg20 micrograms per square centimetre
Health-based, PDE 0.15 mg/day18.75 g750 micrograms per square centimetre

The spread matters more than any single value. Five, twenty and seven hundred and fifty micrograms per square centimetre differ by more than two orders of magnitude. A site that computes only the health-based route, finds 750 and validates to it has validated nothing for a low-dose drug. A site that computes only 10 ppm has no answer when the auditor asks about the sensitising potential of the donor. A site that computes all three and takes the smallest can show the working.

The same exercise proves the opposite point as well: for an ordinary oral product with solid dose data, the health-based route is often the least restrictive of the three. Adopting it everywhere without the arithmetic is as indefensible as ignoring it.

The quantitation limit has to fit under the limit you chose

A swab limit describes a surface, so the method has to be able to see what the limit permits. Staying with 5 micrograms per square centimetre and a swab covering 25 square centimetres, the mass on the swab at the limit is 125 micrograms. Extracted into 10 mL, that is 12.5 micrograms per millilitre.

Recovery changes the figure the instrument has to produce, and it changes it in the direction people get wrong. At 80 per cent recovery, a sample truly carrying the limit reads 10 micrograms per millilitre, not 12.5. The calculation divides by recovery, so the reported surface residue returns to the right value, but the method now has to quantify at 10 and preferably at a third of that, near 3.3 micrograms per millilitre, to leave any margin. A method whose lower limit of quantification sits at 15 micrograms per millilitre cannot demonstrate compliance with a 5 microgram per square centimetre limit, however clean the equipment is; it can report only that the result fell below quantification, which is a different statement.

Recovery also has to be established on the right material. A coupon study on polished stainless steel says nothing about a PTFE gasket, a sight glass or a roughened weld. The figure belongs to a combination of surface, residue and swab, and at low levels it is concentration dependent in a way a single high-level spike will conceal.

What the reference standard contributes to the result

Every microgram per square centimetre reported is a mass obtained from an area through a calibration curve, and the curve rests on one number: the assigned content of a standard. Three properties of that standard move the answer.

  • Content and its basis. A standard assigned at 92.3 per cent as-is, weighed as though it were 100 per cent, makes the calibrator 7.7 per cent weak, and every residue then reads about 8 per cent high. That is conservative, and it is still enough to turn a compliant swab into an investigation. The basis matters as much as the value: a content stated on the dried basis and applied to an undried standard shifts the error the other way. Reading the certificate properly is the cheapest control in the whole method.
  • Form. If the residue is a salt and the standard is the free base, the mass ratio belongs in the calculation exactly as it does in assay work, and the conversion is worked through in the salt and hydrate piece. Salt factors of ten to fifteen per cent are common, and larger than most of the differences under discussion.
  • Traceability and validity. A working standard prepared in-house needs a link to a characterised material and a documented potency assignment. An expired standard needs no interpretation: it invalidates the run, and hygroscopic material weighed straight from the fridge gains water while the analyst is still taring it.

A fourth case is worth naming. Where the parent compound is not available as a standard, the method targets a marker. Choose one shown to be present in the residue at a known and stable ratio to the parent, and state the ratio in the method.

Where these programmes fail

  • A dose fraction applied to an intermediate that is never administered, where the input dose does not exist.
  • The limit recalculated after a batch size change, with no revalidation and no change control record.
  • All three routes computed, then the highest adopted because it was the easiest to pass.
  • Recovery measured once, on one material, at one concentration, several years ago.
  • Cleaning agent residue left out of the calculation, although the detergent has its own acceptance criterion.

Checklist before the next campaign

  • Donor limit: dose-based and health-based both calculated, reports on file, governing route named.
  • Recipient inputs taken from current registered documents, not from memory.
  • Shared area measured or drawn from the equipment file, and updated when a line changes.
  • Surface limit printed with its unit, since 5 micrograms and 5 milligrams per square centimetre both read as a bare 5.
  • Method: quantitation limit at or below a third of the limit after recovery correction.
  • Standard: content, basis, form, storage and retest date checked before anything is weighed.

Frequently asked

Is the 10 ppm criterion still acceptable?
As a calculation, yes; as a justification, no. A concentration ceiling of 10 ppm carries no toxicological information, so it cannot answer a question about the hazard of the residue. Where a health-based limit exists, show that 10 ppm is at least as conservative as it, or adopt the health-based value if it is lower.
Can one thousandth of the dose be used for every product?
Only where a human dose exists to divide. The fraction is meaningless for an intermediate that is never administered, and it is blind to effects that are not an extension of the pharmacological dose, which is why potent, mutagenic and sensitising compounds cannot be handled this way.
My health-based route gives 750 micrograms per square centimetre. Is that the limit?
Only if it is the lowest of the routes that apply. In the worked pair in this article the dose fraction gives 5 and 10 ppm gives 20, so 750 governs nothing. Calculate every available route, keep the smallest, and record why the others were rejected.
Does the standard have to be the parent compound?
No, provided the marker is shown to be present in the residue at a known and stable ratio to the parent, and the method states the ratio. What is not acceptable is a marker chosen for convenience with no evidence that it tracks the residue.
What if the method cannot quantify down to the limit?
Then the limit has not been demonstrated, whatever the equipment looks like. Either improve the method, for example by concentrating the extract, widening the swabbed area or moving to a more sensitive detector, or revisit the basis of the limit. Reporting none detected is not an answer.
How often does the limit have to be recalculated?
Whenever an input changes: a new product on the train, a different batch size, a revised maximum daily dose, a new toxicological assessment, a changed shared area or a modified cleaning procedure. Each of those belongs in change control, not in an annual review.

Sources and further reading

Every document below is published by the body that owns it; none of them is a summary written by us. Accessed 2026-10-28.

Send us a CAS number

Availability, documentation and lead time — answered by the people who handle the batch, not a ticket queue.

Request a quote sales@rssechem.com

How to read a certificate of analysis Field by field: identity, purity, content basis, the retest date, and the questions worth asking a supplier before you file the document.How to choose a reference standard supplier A practical checklist for evaluating reference standard suppliers on documentation, traceability, lot consistency, logistics and technical support.Stable isotope-labelled standards and when to use them When labelled internal standards earn their place in an LC-MS or GC-MS method, what to specify when ordering, and the traps in quantitative work.Nitrosamine and NDSRI standards: what to test for and what to buy The difference between small nitrosamines and NDSRIs, what a laboratory needs as a standard for each, and how to specify one so the result stands up to review.What is an impurity reference standard? What the term means, how it differs from a pharmacopoeial standard and a working standard, what the documentation has to state, and how to pick the right form and purity basis.ICH M7 in practice: classifying mutagenic impurities How the five-class hazard assessment works, what the 1.5 microgram default really covers, and how the four control options decide which standards you buy.qNMR vs mass balance: how purity is really assigned Two certificates, one compound, two purity values. What mass balance and qNMR each measure, why the figures differ, and how the basis changes the number.Elemental impurities: from a PDE to a limit you can measure How a permitted daily exposure becomes a concentration limit, why the dose moves the number, and what an elemental impurity specification must state.Salt, hydrate and free base: converting content so the numbers reconcile How to move content and impurity values between as-is, anhydrous and free-base bases, in what order, and why the basis can turn a pass into a fail.Forced degradation study design: how far to push each stressor How to set stressor strength, read a kinetics screen, judge mass balance and catch over-degradation before it wastes a method development cycle.Analytical method transfer: acceptance criteria you can defend Four transfer routes, criteria built from the method's own precision, and the standard's assigned content that shifts every result by a fixed amount.Chiral and stereoisomeric impurity standards Enantiomer, diastereomer, epimer, E/Z isomer: four different standards and four different questions. What each has to state before it can control a method.Reference standard, analytical standard, CRM: what the words mean Four labels appear on the same vial in different catalogues. They are not synonyms, and the difference decides what you may claim in a report.Peptide reference standards: what changes when the analyte is a chain Deletion sequences, epimers, pyroglutamate, deamidation, counter-ion and water: why a peptide standard needs a different certificate from a small molecule.